This week, Tocagen began enrolling patients in a Phase I trial in which its Toca 511 cancer drug is delivered using a visually guided device called ClearPoint, the first such device of its kind, that allows for a more concentrated delivery, increasing the drug's effectiveness as much as threefold.
Medtronic gained FDA approval for what will become its second MRI-friendly pacer in the United States, and only the second device of its kind to gain a regulatory nod here.
Philips Healthcare has a lot to crow about over its 2012 fourth quarter results, having generated steady growth in all device and medical equipment-related business lines.
The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate without a hitch during an MRI. Over concerns that traditional pacemakers may be unsafe during the procedure, several companies have recently developed devices that can be marketed with MRI compatability mind.
Samsung, the South Korean consumer electronics giant, expects its medical device sales will hit the $500 million mark this year, up from $300 million in 2012.
Today, doctors ask patients to rate their own pain on a scale, relying heavily on what patients say to make their diagnoses. Stanford researchers are working on a more objective measurement, and they have applied computer algorithms to help them pull it off.
Researchers believe combining the use of two imaging systems along with a biomarker diagnostic test can more precisely--and correctly--diagnose patients with mild or early cases of Alzheimer's.
GE Healthcare ($GE), a longtime investor in Israel's InSightec, recently strengthened its hold on the maker of a focused ultrasound device through its role in a recently completed $30.9 million venture financing round and two crucial new appointments to the company's leadership.
Their goal: To create a single, MRI-guided radiation therapy system that blends MRI with precise radiation delivery.
Medtronic is launching its MRI-safe Advisa pacemaker in Japan, the first such device available in the country.